Sherbrooke Park Advisers’s Krystal Biotech KRYS Stock Holding History

Sherbrooke Park Advisers’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$369K	Sell
2024 Q3	$433K	Buy
2024 Q2	$245K	Sell
2024 Q1	$771K	Buy